Handmade quality · Free shipping over $75 · Explore the atelier

ABBV-744 - CAS# 2138861-99-9 48671 was the first drug in

SKU: 98763110385

4.6
USD100.00 USD148.00

Pay in 4 interest-free payments of $25.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

was the first drug in human therapy (market introduction 1995) which resulted from structure-based drug design

Droxidopa is a synthetic amino acid precursor which acts as a prodrug to the neurotransmitters norepinephrine (noradrenaline) and epinephrine (adrenaline) and it is used to increase the concentrations of these neurotransmitters in the body and brain

whereas CoQ9 has been found in high concentrations in corn oil

To test whether PK11007 also increases ROS levels

Epub 2014 May 27

ABBV-744 - CAS# 2138861-99-9 48671 was the first drug inABBV 744 is a first in class, orally active and selective inhibitor of the BDII domain of BET family proteins with IC50 values range from 4 to 18 nM for BRD2, BRD3, BRD4 and BRDT. ABBV 744 is primarily metabolized by CYP3A4 with drug like properties enable the investigation of its antitumor efficacy and tolerability. Product information CAS Number: 2138861 99 9 Molecular Weight: 491. 55 Formula: C28H30FN3O4 Chemical Name: N ethyl 4 [2 (4 fluoro 2,6

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products